Contact
Please use this form to send email to PR contact of this press release:
FDA approves first Factor X concentrate to treat patients with rare hereditary bleeding disorder
TO:
Please use this form to send email to PR contact of this press release:
FDA approves first Factor X concentrate to treat patients with rare hereditary bleeding disorder
TO: